The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Parshall B Lynne | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Gill Simba | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Smith Ian F | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Lynch Thomas J. Jr. | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Mendelsohn Michael | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Biller Scott | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Cole Douglas G. | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Duty Stuart | Director | Grant(A) | 28K | $4.08 | $114K |
| Jun 24, 2026 | Gallagher Neil | Director | Grant(A) | 28K | $4.08 | $114K |
| Apr 10, 2026 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 59K | — | $0 |
| Apr 10, 2026 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 59K | — | $0 |
| Apr 9, 2026 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 47K | — | $0 |
| Apr 9, 2026 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 47K | — | $0 |
| Feb 23, 2026 | Maynard Ryan D | Chief Financial Officer | Grant(A) | 400K | $5.75 | $2.3M |
| Feb 5, 2026 | Gottschalk Adrian | Chief Executive Officer, Director | Grant(A) | 1.1M | $5.23 | $5.6M |
| Jan 30, 2026 | Cardama Alfonso Quintas | Chief Medical Officer | Grant(A) | 300K | $5.71 | $1.7M |
| Jan 30, 2026 | Bellon Steven F. | Chief Scientific Officer | Grant(A) | 300K | $5.71 | $1.7M |
| Jan 30, 2026 | LaCascia Michael | Chief Legal Officer | Grant(A) | 295K | $5.71 | $1.7M |
| Jan 30, 2026 | Costa Carlos | Chief People Officer | Grant(A) | 230K | $5.71 | $1.3M |
| Jan 30, 2026 | Rivkin Anna | Chief Business Officer | Grant(A) | 165K | $5.71 | $942K |
| Jan 13, 2026 | Flagship Ventures Opportunities Fund I General Partner LLC | Director, 10% Owner | Grant(A) | 1.1M | — | — |
| Jan 13, 2026 | Flagship Ventures Opportunities Fund I General Partner LLC | Director, 10% Owner | Grant(A) | 1.1M | — | — |
| Jan 13, 2026 | Flagship Ventures Opportunities Fund I General Partner LLC | Director, 10% Owner | Grant(A) | 2.2M | $6.71 | $15.0M |
| Jun 17, 2025 | Cole Douglas G. | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Biller Scott | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Gill Simba | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Lynch Thomas J. Jr. | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Mendelsohn Michael | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Parshall B Lynne | Director | Grant(A) | 25K | $4.79 | $120K |
| Jun 17, 2025 | Smith Ian F | Director | Grant(A) | 25K | $4.79 | $120K |
| May 1, 2025 | Duty Stuart | Director | Grant(A) | 50K | $4.16 | $208K |
| May 1, 2025 | Gallagher Neil | Director | Grant(A) | 50K | $4.16 | $208K |
| Apr 25, 2025 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 300K | — | $0 |
| Apr 25, 2025 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 300K | — | $0 |
| Apr 9, 2025 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 198K | — | $0 |
| Apr 9, 2025 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 198K | — | $0 |
| Jan 22, 2025 | LaCascia Michael | Chief Legal Officer | Grant(A) | 126K | $4.37 | $551K |
| Jan 22, 2025 | Bellon Steven F. | Chief Scientific Officer | Grant(A) | 140K | $4.37 | $612K |
| Jan 22, 2025 | Gottschalk Adrian | Chief Executive Officer, Director | Grant(A) | 400K | $4.37 | $1.7M |
| Jan 22, 2025 | Rivkin Anna | Chief Business Officer | Grant(A) | 50K | $4.37 | $219K |
| Jan 22, 2025 | Costa Carlos | Chief People Officer | Grant(A) | 115K | $4.37 | $503K |
| Jan 22, 2025 | Humer Kristian | Chief Financial Officer | Grant(A) | 120K | $4.37 | $524K |
| Jan 22, 2025 | Cardama Alfonso Quintas | Chief Medical Officer | Grant(A) | 125K | $4.37 | $546K |
| Sep 23, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 857 | $3.72 | $3K |
| Sep 23, 2024 | Costa Carlos | Chief People Officer | Sell(S) | 857 | $10.17 | $9K |
| Sep 23, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 857 | — | $0 |
| Sep 20, 2024 | Costa Carlos | Chief People Officer | Sell(S) | 36K | $10.04 | $359K |
| Sep 20, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 36K | $3.72 | $133K |
| Sep 20, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 36K | — | $0 |
| Sep 18, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 12K | $3.72 | $43K |
| Sep 18, 2024 | Costa Carlos | Chief People Officer | Sell(S) | 12K | $10.05 | $116K |
| Sep 18, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 12K | — | $0 |
| Sep 17, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 10K | $3.72 | $38K |
| Sep 17, 2024 | Costa Carlos | Chief People Officer | Sell(S) | 10K | $10.04 | $103K |
| Sep 17, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 10K | — | $0 |
| Sep 16, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 400 | $3.72 | $1K |
| Sep 16, 2024 | Costa Carlos | Chief People Officer | Sell(S) | 400 | $10.00 | $4K |
| Sep 16, 2024 | Costa Carlos | Chief People Officer | Option exercise(M) | 400 | — | $0 |
| Sep 9, 2024 | Bellon Steven F. | Chief Scientific Officer | Sell(S) | 20K | $9.50 | $190K |
| Sep 3, 2024 | Rivkin Anna | Chief Business Officer | Grant(A) | 190K | $7.85 | $1.5M |
| Jun 26, 2024 | Koppel Adam | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Parshall B Lynne | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Cole Douglas G. | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Gill Simba | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Lynch Thomas J. Jr. | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Smith Ian F | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Mendelsohn Michael | Director | Grant(A) | 16K | $5.52 | $88K |
| Jun 26, 2024 | Biller Scott | Director | Grant(A) | 16K | $5.52 | $88K |
| May 22, 2024 | Afeyan Noubar | 10% Owner | Buy(P) | 1.8M | $5.51 | $10.0M |
| May 22, 2024 | Afeyan Noubar | 10% Owner | Buy(P) | 1.8M | $5.51 | $10.0M |
| Apr 16, 2024 | Humer Kristian | Chief Financial Officer | Grant(A) | 275K | $6.03 | $1.7M |
| Mar 11, 2024 | Cavalie Fanny | Chief Strategy/Bus Ops Officer | Sell(S) | 11K | $6.56 | $72K |
| Jan 24, 2024 | LaCascia Michael | Chief Legal Officer | Grant(A) | 100K | $3.06 | $306K |
| Jan 24, 2024 | Bellon Steven F. | Chief Scientific Officer | Grant(A) | 110K | $3.06 | $337K |
| Jan 24, 2024 | Costa Carlos | Chief People Officer | Grant(A) | 90K | $3.06 | $275K |
| Jan 24, 2024 | Cavalie Fanny | Chief Strategy/Bus Ops Officer | Grant(A) | 80K | $3.06 | $245K |
| Jan 24, 2024 | Cardama Alfonso Quintas | Chief Medical Officer | Grant(A) | 60K | $3.06 | $184K |
| Jan 24, 2024 | Gottschalk Adrian | Chief Executive Officer, Director | Grant(A) | 300K | $3.06 | $918K |
| Dec 8, 2023 | Smith Ian F | Director | Grant(A) | 27K | — | $0 |
| Sep 11, 2023 | Cardama Alfonso Quintas | Chief Medical Officer | Grant(A) | 272K | $7.57 | $2.1M |
| Aug 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 63K | — | $0 |
| Aug 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 63K | — | $0 |
| Aug 16, 2023 | Agresta Samuel | Chief Medical Officer | Option exercise(M) | 311K | $3.72 | $1.2M |
| Aug 16, 2023 | Agresta Samuel | Chief Medical Officer | Sell(S) | 311K | $8.25 | $2.6M |
| Aug 16, 2023 | Agresta Samuel | Chief Medical Officer | Option exercise(M) | 311K | — | $0 |
| Jun 21, 2023 | Mendelsohn Michael | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Gill Simba | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Koppel Adam | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Biller Scott | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Smith Ian F | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Cole Douglas G. | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Lynch Thomas J. Jr. | Director | Grant(A) | 16K | — | $0 |
| Jun 21, 2023 | Parshall B Lynne | Director | Grant(A) | 16K | — | $0 |
| May 26, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 300K | — | $0 |
| May 26, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 300K | — | $0 |
| Feb 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Other(J) | 185K | — | $0 |
| Feb 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Other(J) | 185K | — | $0 |
| Feb 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 4K | — | $0 |
| Feb 17, 2023 | Gottschalk Adrian | Chief Executive Officer, Director | Gift(G) | 4K | — | $0 |
| Jan 26, 2023 | Reine Allan | Chief Financial Officer | Grant(A) | 90K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).